140 related articles for article (PubMed ID: 38049565)
1. FOXO3a-regulated arginine metabolic plasticity adaptively promotes esophageal cancer proliferation and metastasis.
Sun W; Kou H; Fang Y; Xu F; Xu Z; Wang X; Yin R; Zhang Q; Jiang Q; Xu Y
Oncogene; 2024 Jan; 43(3):216-223. PubMed ID: 38049565
[TBL] [Abstract][Full Text] [Related]
2. Targeting IGF1R signaling enhances the sensitivity of cisplatin by inhibiting proline and arginine metabolism in oesophageal squamous cell carcinoma under hypoxia.
Fang K; Sun M; Leng Z; Chu Y; Zhao Z; Li Z; Zhang Y; Xu A; Zhang Z; Zhang L; Chen T; Xu M
J Exp Clin Cancer Res; 2023 Mar; 42(1):73. PubMed ID: 36978187
[TBL] [Abstract][Full Text] [Related]
3. ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism.
Khare S; Kim LC; Lobel G; Doulias PT; Ischiropoulos H; Nissim I; Keith B; Simon MC
Cancer Metab; 2021 Dec; 9(1):40. PubMed ID: 34861885
[TBL] [Abstract][Full Text] [Related]
4. Cyclic adenosine monophosphate-induced argininosuccinate synthase 1 expression is essential during mouse decidualization.
Huang Z; Wang TS; Zhao YC; Zuo RJ; Deng WB; Chi YJ; Yang ZM
Mol Cell Endocrinol; 2014 May; 388(1-2):20-31. PubMed ID: 24556046
[TBL] [Abstract][Full Text] [Related]
5. Reduced argininosuccinate synthetase expression in refractory sarcomas: Impacts on therapeutic potential and drug resistance.
Kim Y; Kobayashi E; Kubota D; Suehara Y; Mukaihara K; Akaike K; Ito A; Kaneko K; Chuman H; Kawai A; Kitano S
Oncotarget; 2016 Oct; 7(43):70832-70844. PubMed ID: 27683125
[TBL] [Abstract][Full Text] [Related]
6. Sustained generation of nitric oxide and control of mycobacterial infection requires argininosuccinate synthase 1.
Qualls JE; Subramanian C; Rafi W; Smith AM; Balouzian L; DeFreitas AA; Shirey KA; Reutterer B; Kernbauer E; Stockinger S; Decker T; Miyairi I; Vogel SN; Salgame P; Rock CO; Murray PJ
Cell Host Microbe; 2012 Sep; 12(3):313-23. PubMed ID: 22980328
[TBL] [Abstract][Full Text] [Related]
7. A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma.
Phillips MM; Pavlyk I; Allen M; Ghazaly E; Cutts R; Carpentier J; Berry JS; Nattress C; Feng S; Hallden G; Chelala C; Bomalaski J; Steele J; Sheaff M; Balkwill F; Szlosarek PW
Pharmacol Rep; 2023 Jun; 75(3):570-584. PubMed ID: 37010783
[TBL] [Abstract][Full Text] [Related]
8. N(6)-adenosine-methyltransferase-14 promotes glioma tumorigenesis by repressing argininosuccinate synthase 1 expression in an m6A-dependent manner.
Miao YQ; Chen W; Zhou J; Shen Q; Sun Y; Li T; Wang SC
Bioengineered; 2022 Jan; 13(1):1858-1871. PubMed ID: 35012429
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging.
Allen MD; Luong P; Hudson C; Leyton J; Delage B; Ghazaly E; Cutts R; Yuan M; Syed N; Lo Nigro C; Lattanzio L; Chmielewska-Kassassir M; Tomlinson I; Roylance R; Whitaker HC; Warren AY; Neal D; Frezza C; Beltran L; Jones LJ; Chelala C; Wu BW; Bomalaski JS; Jackson RC; Lu YJ; Crook T; Lemoine NR; Mather S; Foster J; Sosabowski J; Avril N; Li CF; Szlosarek PW
Cancer Res; 2014 Feb; 74(3):896-907. PubMed ID: 24285724
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer.
Nicholson LJ; Smith PR; Hiller L; Szlosarek PW; Kimberley C; Sehouli J; Koensgen D; Mustea A; Schmid P; Crook T
Int J Cancer; 2009 Sep; 125(6):1454-63. PubMed ID: 19533750
[TBL] [Abstract][Full Text] [Related]
11. Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer.
Delage B; Fennell DA; Nicholson L; McNeish I; Lemoine NR; Crook T; Szlosarek PW
Int J Cancer; 2010 Jun; 126(12):2762-72. PubMed ID: 20104527
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the Polyamine Synthesis Pathway Is Synthetically Lethal with Loss of Argininosuccinate Synthase 1.
Locke M; Ghazaly E; Freitas MO; Mitsinga M; Lattanzio L; Lo Nigro C; Nagano A; Wang J; Chelala C; Szlosarek P; Martin SA
Cell Rep; 2016 Aug; 16(6):1604-1613. PubMed ID: 27452468
[TBL] [Abstract][Full Text] [Related]
13. Argininosuccinate synthetase 1 (ASS1) is a common metabolic marker of chemosensitivity for targeted arginine- and glutamine-starvation therapy.
Long Y; Tsai WB; Wang D; Hawke DH; Savaraj N; Feun LG; Hung MC; Chen HH; Kuo MT
Cancer Lett; 2017 Mar; 388():54-63. PubMed ID: 27913198
[TBL] [Abstract][Full Text] [Related]
14. Argininosuccinate synthetase 1 suppression and arginine restriction inhibit cell migration in gastric cancer cell lines.
Shan YS; Hsu HP; Lai MD; Yen MC; Chen WC; Fang JH; Weng TY; Chen YL
Sci Rep; 2015 Apr; 5():9783. PubMed ID: 25928182
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy.
McAlpine JA; Lu HT; Wu KC; Knowles SK; Thomson JA
BMC Cancer; 2014 Aug; 14():621. PubMed ID: 25164070
[TBL] [Abstract][Full Text] [Related]
16. lncRNA PART1, manipulated by transcriptional factor FOXP2, suppresses proliferation and invasion in ESCC by regulating the miR‑18a‑5p/SOX6 signaling axis.
Zhao Y; Zhang Q; Liu H; Wang N; Zhang X; Yang S
Oncol Rep; 2021 Mar; 45(3):1118-1132. PubMed ID: 33432363
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma.
Syed N; Langer J; Janczar K; Singh P; Lo Nigro C; Lattanzio L; Coley HM; Hatzimichael E; Bomalaski J; Szlosarek P; Awad M; O'Neil K; Roncaroli F; Crook T
Cell Death Dis; 2013 Jan; 4(1):e458. PubMed ID: 23328665
[TBL] [Abstract][Full Text] [Related]
18. Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity.
Zhang W; Yan W; Qian N; Han Q; Zhang W; Dai G
Chin Med J (Engl); 2022 Feb; 135(5):606-618. PubMed ID: 35191417
[TBL] [Abstract][Full Text] [Related]
19. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X
Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis.
Delage B; Luong P; Maharaj L; O'Riain C; Syed N; Crook T; Hatzimichael E; Papoudou-Bai A; Mitchell TJ; Whittaker SJ; Cerio R; Gribben J; Lemoine N; Bomalaski J; Li CF; Joel S; Fitzgibbon J; Chen LT; Szlosarek PW
Cell Death Dis; 2012 Jul; 3(7):e342. PubMed ID: 22764101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
